COMPREHENSIVE EXAM REVIEW
TEST BANK WITH REAL EXAM
LATEST MOCK PRACTICE SET
185 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NUR 507 EXAMS 1-6 COMPREHENSIVE EXAM REVIEW TEST BANK WITH REAL EXAM QUESTIONS AND
CORRECT ANSWERS GRADED A+ ST THOMAS UNIVERSITY / NUR 507 ADVANCED FAMILY NURSE
PRACTITIONER 1 CHILDREN AND FAMILIES PREP. It contains 185 carefully selected questions that reflect the
most current exam content and testing strategies. Each question is accompanied by a correct answer and a
detailed rationale that explains the underlying concepts and reasoning required to master the material.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering questions
under simulated exam
conditions
Review Summary 185 Questions
Foundations - Application - NUR 507 Exams 1-6 Comprehensive Review BANK WITH REAL AND Correct
A ST Thomas University / NUR 507 Advanced Family Nurse Practitioner 1 Children AND Families PREP
Advanced Pediatric Primary CARE Graduate Doctor OF Nursing / Family Nurse Practitioner
All answers with rationales
,Table of Contents
Section A - Growth AND Development Section B - Pediatric Health
Questions 1 to 47 Assessment
Questions 48 to 94
Section C - Common Acute Illnesses Section D - Chronic Illness
IN Children Management
Questions 95 to 141 Questions 142 to 185
,Section A - Growth AND Development
Q1.
A 10-month-old presents with failure to thrive. Weight and length are below the 3rd
percentile. Which diagnostic approach is most appropriate after initial history and
physical?
A. Order a comprehensive metabolic panel B. Refer to pediatric gastroenterology for
and celiac serology only. endoscopy and biopsy.
C. Assess caloric intake with a 3-day food D. Obtain growth chart review and parental
diary and a trial of high-calorie formula. heights; no further workup needed at this
time.
Correct: C - Assess caloric intake with a 3-day food diary and a trial of high-calorie
formula.
Rationale:
In failure to thrive, the initial approach should assess caloric intake and address feeding
issues. A 3-day food diary and calorie supplementation are first-line interventions. Extensive
testing is reserved for those who fail to respond.
Q2.
Which of the following best describes the evidence-based recommendation for screening
for developmental dysplasia of the hip (DDH) in infants?
A. Universal ultrasound screening of all B. Selective ultrasound screening for infants
newborns at birth. with risk factors (breech presentation, family
history) and abnormal physical exam.
C. Universal physical exam at all well-child D. No routine screening; symptomatic cases
visits; imaging only if exam is abnormal. are managed at the time of diagnosis.
Correct: B - Selective ultrasound screening for infants with risk factors (breech
presentation, family history) and abnormal physical exam.
Rationale:
The US Preventive Services Task Force recommends selective screening for DDH: physical
exam at birth and well-child visits, with ultrasound reserved for those with risk factors or
abnormal exam. Universal ultrasound is not recommended.
Q3.
A 6-year-old child with asthma is poorly controlled despite low-dose inhaled
corticosteroid (ICS) therapy. Which step is most appropriate per NHLBI guidelines?
Page 3
, Section A - Growth AND Development
A. Add a long-acting beta-agonist (LABA) to B. Increase ICS to medium dose and
the current ICS dose. reevaluate in 4-6 weeks.
C. Switch to a leukotriene receptor D. Refer to a pulmonologist for
antagonist monotherapy. consideration of biologic therapy.
Correct: A - Add a long-acting beta-agonist (LABA) to the current ICS dose.
Rationale:
For children 4-11 years with poor control on low-dose ICS, the preferred step-up is to add a
LABA (or increase to medium-dose ICS). This aligns with NHLBI EPR-3 guidelines. Biologics
are reserved for severe persistent asthma.
Q4.
In which of the following clinical scenarios is the use of oral antiviral therapy for
respiratory syncytial virus (RSV) indicated?
A. Prophylaxis in high-risk infants during B. Treatment of mild bronchiolitis in an
RSV season. otherwise healthy toddler.
C. Treatment of severe lower respiratory D. Oral antivirals are not recommended for
tract infection in an immunocompromised RSV; only ribavirin via inhalation is used.
child.
Correct: D - Oral antivirals are not recommended for RSV; only ribavirin via inhalation is
used.
Rationale:
There is no oral antiviral approved for RSV. Ribavirin is the only antiviral, used via inhalation
in severe cases in immunocompromised patients. Palivizumab is used for prophylaxis in
high-risk infants.
Q5.
A 3-year-old child presents with acute otitis media (AOM) for the second time in 6 months.
The child has no antibiotic allergy. Which antibiotic is first-line per AAP guidelines?
A. Azithromycin 10 mg/kg/day for 3 days. B. Amoxicillin-clavulanate 90 mg/kg/day of
amoxicillin component.
C. Cefpodoxime 10 mg/kg/day for 10 days. D. Amoxicillin 90 mg/kg/day for 10 days.
Correct: B - Amoxicillin-clavulanate 90 mg/kg/day of amoxicillin component.
Rationale:
For AOM in children with severe symptoms or recurrent episodes, amoxicillin-clavulanate is
recommended due to beta-lactamase producing organisms. High-dose amoxicillin is first-line
for initial AOM without severe features.
Page 4